vs
Side-by-side financial comparison of LOGITECH INTERNATIONAL S.A. (LOGI) and Zoetis (ZTS). Click either name above to swap in a different company.
Zoetis is the larger business by last-quarter revenue ($2.4B vs $1.4B, roughly 1.7× LOGITECH INTERNATIONAL S.A.). Zoetis runs the higher net margin — 25.3% vs 17.7%, a 7.6% gap on every dollar of revenue. On growth, LOGITECH INTERNATIONAL S.A. posted the faster year-over-year revenue change (6.1% vs 3.0%). Zoetis produced more free cash flow last quarter ($732.0M vs $465.6M). Over the past eight quarters, LOGITECH INTERNATIONAL S.A.'s revenue compounded faster (18.5% CAGR vs 4.4%).
Logitech International S.A. is a Swiss multinational manufacturer of computer peripherals and software. Headquartered in Lausanne, Switzerland, the company has offices throughout Europe, Asia, Oceania, and the Americas. It is a component of the Swiss Market Index, and is listed on the Nasdaq.
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total re...
LOGI vs ZTS — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $2.4B |
| Net Profit | $251.0M | $603.0M |
| Gross Margin | 43.2% | 70.2% |
| Operating Margin | 20.1% | 31.9% |
| Net Margin | 17.7% | 25.3% |
| Revenue YoY | 6.1% | 3.0% |
| Net Profit YoY | 25.4% | 3.8% |
| EPS (diluted) | $1.69 | $1.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $2.4B | ||
| Q3 25 | $1.2B | $2.4B | ||
| Q2 25 | $1.1B | $2.5B | ||
| Q1 25 | $1.0B | $2.2B | ||
| Q4 24 | $1.3B | $2.3B | ||
| Q3 24 | $1.1B | $2.4B | ||
| Q2 24 | $1.1B | $2.4B | ||
| Q1 24 | $1.0B | $2.2B |
| Q4 25 | $251.0M | $603.0M | ||
| Q3 25 | $170.7M | $721.0M | ||
| Q2 25 | $146.0M | $718.0M | ||
| Q1 25 | $144.1M | $631.0M | ||
| Q4 24 | $200.1M | $581.0M | ||
| Q3 24 | $145.5M | $682.0M | ||
| Q2 24 | $141.8M | $624.0M | ||
| Q1 24 | $167.6M | $599.0M |
| Q4 25 | 43.2% | 70.2% | ||
| Q3 25 | 43.4% | 71.5% | ||
| Q2 25 | 41.7% | 73.6% | ||
| Q1 25 | 43.1% | 72.0% | ||
| Q4 24 | 42.9% | 69.5% | ||
| Q3 24 | 43.6% | 70.6% | ||
| Q2 24 | 42.8% | 71.7% | ||
| Q1 24 | 43.2% | 70.6% |
| Q4 25 | 20.1% | 31.9% | ||
| Q3 25 | 16.1% | 37.0% | ||
| Q2 25 | 14.1% | 36.7% | ||
| Q1 25 | 10.5% | 36.5% | ||
| Q4 24 | 17.5% | 31.6% | ||
| Q3 24 | 14.4% | 36.6% | ||
| Q2 24 | 14.1% | 33.0% | ||
| Q1 24 | 12.9% | 34.1% |
| Q4 25 | 17.7% | 25.3% | ||
| Q3 25 | 14.4% | 30.0% | ||
| Q2 25 | 12.7% | 29.2% | ||
| Q1 25 | 14.3% | 28.4% | ||
| Q4 24 | 14.9% | 25.1% | ||
| Q3 24 | 13.0% | 28.6% | ||
| Q2 24 | 13.0% | 26.4% | ||
| Q1 24 | 16.6% | 27.4% |
| Q4 25 | $1.69 | $1.37 | ||
| Q3 25 | $1.15 | $1.63 | ||
| Q2 25 | $0.98 | $1.61 | ||
| Q1 25 | $0.94 | $1.41 | ||
| Q4 24 | $1.32 | $1.29 | ||
| Q3 24 | $0.95 | $1.50 | ||
| Q2 24 | $0.92 | $1.37 | ||
| Q1 24 | $1.07 | $1.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.3B | $3.3B |
| Total Assets | $4.1B | $15.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.4B | $2.1B | ||
| Q2 25 | $1.5B | $1.4B | ||
| Q1 25 | $1.5B | $1.7B | ||
| Q4 24 | $1.5B | $2.0B | ||
| Q3 24 | $1.4B | $1.7B | ||
| Q2 24 | $1.5B | $1.6B | ||
| Q1 24 | $1.5B | $2.0B |
| Q4 25 | $2.3B | $3.3B | ||
| Q3 25 | $2.1B | $5.4B | ||
| Q2 25 | $2.2B | $5.0B | ||
| Q1 25 | $2.1B | $4.7B | ||
| Q4 24 | $2.1B | $4.8B | ||
| Q3 24 | $2.1B | $5.2B | ||
| Q2 24 | $2.2B | $5.0B | ||
| Q1 24 | $2.2B | $5.1B |
| Q4 25 | $4.1B | $15.5B | ||
| Q3 25 | $3.7B | $15.2B | ||
| Q2 25 | $3.7B | $14.5B | ||
| Q1 25 | $3.5B | $14.1B | ||
| Q4 24 | $3.7B | $14.2B | ||
| Q3 24 | $3.6B | $14.4B | ||
| Q2 24 | $3.7B | $14.2B | ||
| Q1 24 | $3.6B | $14.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $480.5M | $893.0M |
| Free Cash FlowOCF − Capex | $465.6M | $732.0M |
| FCF MarginFCF / Revenue | 32.8% | 30.7% |
| Capex IntensityCapex / Revenue | 1.0% | 6.7% |
| Cash ConversionOCF / Net Profit | 1.91× | 1.48× |
| TTM Free Cash FlowTrailing 4 quarters | $903.6M | $2.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $480.5M | $893.0M | ||
| Q3 25 | $228.8M | $938.0M | ||
| Q2 25 | $125.0M | $486.0M | ||
| Q1 25 | $129.7M | $587.0M | ||
| Q4 24 | $370.9M | $905.0M | ||
| Q3 24 | $166.0M | $951.0M | ||
| Q2 24 | $176.0M | $502.0M | ||
| Q1 24 | $239.1M | $595.0M |
| Q4 25 | $465.6M | $732.0M | ||
| Q3 25 | $212.3M | $805.0M | ||
| Q2 25 | $108.8M | $308.0M | ||
| Q1 25 | $116.9M | $438.0M | ||
| Q4 24 | $356.6M | $689.0M | ||
| Q3 24 | $151.5M | $784.0M | ||
| Q2 24 | $161.4M | $370.0M | ||
| Q1 24 | $228.8M | $455.0M |
| Q4 25 | 32.8% | 30.7% | ||
| Q3 25 | 17.9% | 33.5% | ||
| Q2 25 | 9.5% | 12.5% | ||
| Q1 25 | 11.6% | 19.7% | ||
| Q4 24 | 26.6% | 29.7% | ||
| Q3 24 | 13.6% | 32.8% | ||
| Q2 24 | 14.8% | 15.7% | ||
| Q1 24 | 22.6% | 20.8% |
| Q4 25 | 1.0% | 6.7% | ||
| Q3 25 | 1.4% | 5.5% | ||
| Q2 25 | 1.4% | 7.2% | ||
| Q1 25 | 1.3% | 6.7% | ||
| Q4 24 | 1.1% | 9.3% | ||
| Q3 24 | 1.3% | 7.0% | ||
| Q2 24 | 1.3% | 5.6% | ||
| Q1 24 | 1.0% | 6.4% |
| Q4 25 | 1.91× | 1.48× | ||
| Q3 25 | 1.34× | 1.30× | ||
| Q2 25 | 0.86× | 0.68× | ||
| Q1 25 | 0.90× | 0.93× | ||
| Q4 24 | 1.85× | 1.56× | ||
| Q3 24 | 1.14× | 1.39× | ||
| Q2 24 | 1.24× | 0.80× | ||
| Q1 24 | 1.43× | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LOGI
| Retail Gaming | $482.7M | 34% |
| Retail Keyboards Desktops | $254.6M | 18% |
| Retail Pointing Devices | $241.2M | 17% |
| Retail Video Collaboration | $193.3M | 14% |
| Retail Tablet And Other Accessories | $93.6M | 7% |
| Retail Webcams | $82.3M | 6% |
| Retail Headsets | $45.9M | 3% |
| Other Retail Products | $28.0M | 2% |
ZTS
| Other | $1.3B | 56% |
| Livestock | $234.0M | 10% |
| Pain Sedation | $209.0M | 9% |
| Other Pharmaceuticals | $188.0M | 8% |
| Swine | $125.0M | 5% |
| Poultry | $117.0M | 5% |
| Fish | $81.0M | 3% |
| Other Non Pharmaceuticals | $70.0M | 3% |
| Manufactured Product Other | $18.0M | 1% |
| Medicated Feed Additives | $12.0M | 1% |
